24 May 2013
Keywords: encouraging, ph, iia, data, allergy, thera, vacc
Article | 23 April 2007
UK-based Allergy Therapeutics has reported positive results from a Phase IIa trial of an oral allergy vaccine, which was assessed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 April 2007
23 May 2013
© 2013 thepharmaletter.com